Amgen wins one, loses one in biosimilar battle
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA panel recommends Amgen biosimilar drug for approval
A Food and Drug Administration panel recommended an Amgen biosimilar drug for approval July 12, just days after it said the biosimilar performed like a drug it mimicked. ABP 501, made by Thousand Oaks biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and Read More →
Goleta’s Resonant buys GVR Trade SA for $1.1 million
Resonant, a late stage Goleta development company designing small smartphone technology, announced it bought Switzerland-based GVR Trade SA on July 8 for $1.1 million in stock and cash. Resonant designs a smartphone component called a duplexer. The duplexer acts as a phone’s eyes. A set of filters inside the duplexer selects which radio frequencies to Read More →
Inphi sells memory product business for $90 million
Inphi sold its memory product business to Rambus for $90 million in cash June 30. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a large engineering force in Thousand Oaks. The sale will allow it to focus on its communications business, Inphi said in Read More →
State budget to fund more UC campus startup incubators
Startups around the state got a boost with the stroke of Gov. Jerry Brown’s pen June 27 when he signed the state’s $171 billion budget. Included was $22 million earmarked for startup incubators at all 10 UC campuses. Assemblywoman Jacqui Irwin, D-Thousand Oaks, proposed the initiative, which will give $2 million every year for three Read More →
Stellar Biotechnologies uses limpets to develop medicine
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.